Professional
Added to YB: 2024-01-17
Pitch date: 2024-01-17
LQDA [bullish]
Liquidia Corporation
+485.97%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
Market Cap
$6.0B
Pitch Price
$13.47
Price Target
N/A
Dividend
N/A
EV/EBITDA
125.43
P/E
278.59
EV/Sales
20.86
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Liquidia (LQDA)
A summary for this pitch has not been created yet.
Read full article (1 min)